Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/19/15 → 10/11/18 |
Funding
- Celldex Therapeutics Incorporated: $78,725.00
Randomized Multicenter Pivotal Study of CDX-011(CR011-vcMMAE) in Patients with Metastatic, GPNMB Over-Expressing, Triple-Negative Breast Cancer (METRIC Study)
- Stopeck, Alison (PI)
- Baer, Lea (CoPI)
- Cohen, Jules (CoPI)
- Kudelka, Andrzej (CoPI)
Project: Research